🔎 Trials Near Me

Beranda › Kardiomiopati › New York

Uji klinis Kardiomiopati di New York

14 studi untuk Kardiomiopati mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

  • Weill Cornell Medicine, New York
Menerima pesertaFase 1
Usia 12 hingga 50 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05302271

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Manhasset
  • Clinical Trial Site, New York
  • Clinical Trial Site, New York
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07052903

Targeted Ablation to Isolate Scar Channels Causing Ventricular Tachycardia

  • Westchester Medical Center, Valhalla
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07814079

Impella Reverse Remodeling in End-Stage Heart Failure

  • Columbia University, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06800716

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

  • Cuimc/Nyph, New York
Menerima pesertaFase 2
Usia 0 hingga 16 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06080074

Cardiovascular Multimodality Imaging Study

  • Montefiore Health System, The Bronx
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06610019

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • New York University (NYU) School of Medicine - Langone Medical Center, New York
  • Mount Sinai Hospital, New York
  • Columbia University Medical Center, New York
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895

Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)

  • Weill Cornell Medicine, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 12 hingga 50 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT02316314

Danon Disease Natural History Study

  • Columbia University Medical Center/New York Presbyterian, New York
Menerima pesertaStudi observasional
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT06214507

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

  • Columbia University Medical Center, New York
  • University of Rochester, Rochester
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT05034432

Psychosocial Support for Patients With Takotsubo Syndrome

  • Weill Cornell Medicine, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT05977049

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • New York University (NYU) School of Medicine - Langone Medical Center, New York
  • Columbia University Medical Center, New York
Menerima pesertaFase 3
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06128629

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

  • Suny Downstate, Brooklyn
  • New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn
  • University of Rochester Medical Center, Rochester
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2025 · NCT06964464

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

  • University of Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Mei 2025 · NCT06976606

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.